Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases

Immunologic Research

Volumn 61, Issue 1-2, 2015, Pages 97-103

  Rojas, Carmen Maria Lara ^a   Borella, Elisabetta ^b   Palma, Lavinia ^b   Ragozzino, Silvio ^c   De Ramón, Enrique ^a   Gomez Huelgas, Ricardo ^a,d   Punzi, Leonardo ^b   Doria, Andrea ^b  

^a University Clinic Hospital   (Spain)

^b UNIVERSITY OF PADOVA   (Italy)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

Autoimmune diseases; Bronchiolitis obliterans organizing pneumonia; Polymyositis dermatomyositis; Sj gren s syndrome; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

CORTICOSTEROID;

ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL FEATURE; DEMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; OUTCOME ASSESSMENT; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; AUTOIMMUNE DISEASES; COMPLICATION; CRYPTOGENIC ORGANIZING PNEUMONIA; RHEUMATIC DISEASES;

AUTOIMMUNE DISEASES; CRYPTOGENIC ORGANIZING PNEUMONIA; HUMANS; RHEUMATIC DISEASES;

EID: 84925487259     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-014-8607-z     Document Type: Article

References (46)

1. Cordier JF. Cryptogenic organising pneumonia. Eur Respir J. 2006;28:422–46.
2. Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN. Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med. 2008;3:67–75.
3. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med. 2001;161:158–64.
4. King TE. Cryptogenic organizing pneumonia. In: www.uptodate.com. 2013. http://www.uptodate/contents/cryptogenic-organizing-pneumonia/contributors. (Accessed 14 Jan 2014).
5. Sveinsson OA, Isakson HJ, Gudmundsson G. Organising pneumonia—a review and results from Icelandic studies. Laeknabladid. 2008;94:27–35.
6. Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltim). 1995;74:201–11.
7. Roos JC, Chilvers ER, Ostor AJ. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy. J Rheumatol. 2007;34:238–9.
8. Villeneuve E, St-Pierre A, Haraoui B. Interstitial pneumonitis associated with infliximab therapy. J Rheumatol. 2006;33:1189–93.
9. Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C, et al. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum. 2011;41:256–64.
10. Ostör AJ, Chilvers ER, Somerville MF, et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol. 2006;33:622–8.
11. Cho SK, Oh IH, Park CK, Bae SC, Sung YK. Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis. Rheumatol Int. 2012;32:1055–7.
12. Sakaida H, Komase Y, Takemura T. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept. Mod Rheumatol. 2010;20:611–6.
13. Ikegawa K, Hanaoka M, Ushiki A, Yamamoto H, Kubo K. A case of organizing pneumonia induced by tocilizumab. Intern Med. 2011;50:2191–3.
14. Godeau B, Cormier C, Menkes CJ. Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide. Ann Rheum Dis. 1991;50:956–8.
15. Weber F, Prior C, Kowald E, Schmuth M, Sepp N. Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus. Br J Dermatol. 2000;143:453–5.
16. Purcell IF, Bourke SJ, Marshall SM. Cyclophosphamide in severe steroid-resistant bronchiolitis obliterans organizing pneumonia. Respir Med. 1997;91:175–7.
17. Kondoh Y, Taki F, Ando M, et al. A case of bronchiolitis obliterans organizing pneumonia in a patient with rheumatoid arthritis who responded to corticosteroid and immunosupressant therapy. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30:1165–70.
18. Shinohara T, Hidaka T, Matsuki Y, et al. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med. 1997;36:519–23.
19. Koinuma D, Miki M, Ebina M, et al. Successful treatment of a case with rapidly progressive Bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid. Intern Med. 2002;41:26–9.
20. Kobayashi I, Yamada M, Takahashi Y, et al. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. Rheumatology (Oxf). 2003;42:371–4.
21. Yáñez VJ, Cisternas MM, Saldías HV, Saldías PF. Refractory dermatomyositis associated with chronic organizing pneumonia treated with rituximab: report of one case. Rev Med Chile. 2009;137:88–93.
22. Laszlo A, Espolio Y, Auckenthaler A, Michel JP, Janssens JP. Azathioprine and low-dose corticosteroids for the treatment of cryptogenic organizing pneumonia in an older patient. J Am Geriatr Soc. 2003;51:433–4.
23. Lee YH, Choi SJ, Ji JD, Shim JJ, et al. Dermatomyositis without elevation of creatine kinase presented as bronchiolitis obliterans organizing pneumonia. Korean J Intern Med. 2000;15:85–8.
24. Strobel ES, Bonnet RB, Werner P, Schaefer HE, Peter HH. Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosis-like lung involvement in a patient with primary biliary cirrhosis. Clin Rheumatol. 1998;17:246–9.
25. Yoo JW, Song JW, Jang SJ, Lee CK, et al. Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia. Rheumatology (Oxf). 2011;50:932–8.
26. Cohen AJ, King TE Jr, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med. 1994;149:1670–5.
27. Knoell KA, Hook M, Grice P, Hendrix JD. Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP). J Am Acad Dermatol. 1999;40:328–30.
28. Chan WM, Lau CS, Wang E, Peh WC. Anti-Jo-1 syndrome presenting as cryptogenic organizing pneumonia. Respir Med. 1995;89:639–41.
29. Henriet AC, Diot E, Marchand-Adam S, et al. Organising pneumonia can be the inaugural manifestation in connective tissue diseases, including Sjogren’s syndrome. Eur Respir Rev. 2010;19:161–3.
30. Takada H, Saito Y, Nomura A, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in systemic lupus erythematosus. Pediatr Pulmonol. 2005;40:257–60.
31. Gammon RB, Bridges TA, Al-Nezir H, Alexander CB, Kennedy JI. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest. 1992;102:1171–4.
32. Kalenian M, Zweiman B. Inflammatory myopathy, bronchiolitis obliterans organizing pneumonia and anti-Jo-1 antibodies an interesting association. Clin Diagn Lab Immunol. 1997;4:236–40.
33. Shimizu Y, Tsukagoshi H, Nemoto T, et al. Recurrent bronchiolitis obliterans organizing pneumonia in a patient with limited cutaneous systemic sclerosis. Rheumatol Int. 2002;22:216–8.
34. Taylor JG, Bolster MB. Bronchiolitis obliterans with organizing pneumonia associated with scleroderma and scleroderma spectrum diseases. J Clin Rheumatol. 2003;9:239–45.
35. Otsuka F, Amano T, Hashimoto N, et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody. Intern Med. 1996;35:341–4.
36. Krishnappriya R, Gupta R, Christopher DJ, Balamugesh T, James P. Bronchiolitis obliterans organising pneumonia in systemic lupus erythematosus with anti-phospholipid antibody syndrome—an unusual presentation. Clin Respir J. 2010;4:125–6.
37. Hsue YT, Paulus HE, Coulson WF. Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with long term survival. J Rheumatol. 1993;20:877–9.
38. Imasaki T, Yoshi A, Tanaka S, et al. Polymyositis and Sjögren’s syndrome associated with bronchiolitis obliterans organizing pneumonia. Intern Med. 1996;35:231–5.
39. Fata F, Rathore R, Schiff C, Herzlich BC. Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis. South Med J. 1997;90:227–30.
40. Xing M, Lansdale TF, McNamara CF, et al. Bronchiolitis obliterans with organizing pneumonia (BOOP) heralding anti-Jo-1-positive polymyositis. J Clin Rheumatol. 1999;5:219–23.
41. Devos FG, Leleu O, Aubry P, Jounieaux V. Bronchiolitis obliterans organizing pneumonia associated with dermatomyositis and antiphospholipid syndrome. Rev Mal Respir. 2002;19:249–51.
42. Park SH, Kum YS, Kim KC, et al. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature. Rheumatol Int. 2009;29:1231–5.
43. Mane F, Mets T, Vzncken W, et al. The association of bronchiolitis obliterans organizing pneumonia, systemic lupus erythematosus, and Hunner’s cystitis. Chest. 1993;104:642–4.
44. Lambert M, Hebbar M, Viget N, et al. Bronchiolite oblitkante avec pneumopathie organike: une complication rare du syndrome de Gougerot–Sjiigren primitive. M Rev MCd Interne. 2000;21:74–7.
45. Ioannou S, Toya SP, Tomos P, Tzelepis GE. Cryptogenic organizing pneumonia associated with primary Sjogren’s syndrome. Rheumatol Int. 2008;28:1053–5.
46. Nakamura H, Kita J, Kawakami A, et al. Multiple bone fracture due to Fanconi’s syndrome in primary Sjögren’s syndrome complicated with organizing pneumonia. Rheumatol Int. 2009;30:265–7.